Cargando…

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation

Clinical data indicate that patients with C-reactive protein (CRP) levels higher than 2 mg per liter suffer from persistent inflammation, which is associated with high risk of cardiovascular disease (CVD). We determined whether a panel of biomarkers associated with CVD could predict recurrent events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-Colio, Luis M., Méndez-Barbero, Nerea, Pello Lázaro, Ana María, Aceña, Álvaro, Tarín, Nieves, Cristóbal, Carmen, Martínez-Milla, Juan, González-Lorenzo, Óscar, Martín-Ventura, José Luis, Huelmos, Ana, Gutiérrez-Landaluce, Carlos, López-Castillo, Marta, Kallmeyer, Andrea, Cánovas, Ester, Alonso, Joaquín, López Bescós, Lorenzo, Egido, Jesús, Lorenzo, Óscar, Tuñón, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963189/ https://www.ncbi.nlm.nih.gov/pubmed/33803115 http://dx.doi.org/10.3390/jcm10051137

Ejemplares similares

Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes
por: Lorenzo-Almorós, Ana, et al.
Publicado: (2020)

Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions
por: Kallmeyer, Andrea, et al.
Publicado: (2023)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
por: Martínez-Milla, Juan, et al.
Publicado: (2022)

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
por: Tuñón, José, et al.
Publicado: (2021)

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients
por: Gutiérrez‐Landaluce, Carlos, et al.
Publicado: (2021)

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease
por: Tuñón, José, et al.
Publicado: (2015)

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2017)

Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
por: Tuñón, José, et al.
Publicado: (2014)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2020)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
por: Martín-Reyes, Roberto, et al.
Publicado: (2016)

Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2021)

The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study
por: Venegas‐Rodríguez, Ana, et al.
Publicado: (2023)

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial
por: Tuñón, José, et al.
Publicado: (2016)

Statin use is associated with reduced mortality after respiratory viral infection
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2021)

Targeting metabolic disturbance in the diabetic heart
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2015)

Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
por: Picatoste, Belén, et al.
Publicado: (2013)

Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes
por: López‐Castillo, Marta, et al.
Publicado: (2020)

TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice
por: Fernández-Laso, Valvanera, et al.
Publicado: (2017)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
por: Devesa, Ana, et al.
Publicado: (2021)

COVID-19, MORE THAN JUST RESPIRATORY DISTRESS DISORDER
por: Nieto-Roca, Luis, et al.
Publicado: (2021)

Takotsubo syndrome after mitral valve surgery: a case report
por: Devesa, Ana, et al.
Publicado: (2020)

Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart
por: Hang, Tianyu, et al.
Publicado: (2023)

Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study
por: Devesa, Ana, et al.
Publicado: (2022)

Animal Models of Cardiovascular Diseases
por: Zaragoza, Carlos, et al.
Publicado: (2011)

Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)

Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)

Cellular Crosstalk between Endothelial and Smooth Muscle Cells in Vascular Wall Remodeling
por: Méndez-Barbero, Nerea, et al.
Publicado: (2021)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
por: Méndez-Barbero, Nerea, et al.
Publicado: (2019)

Diagnostic approaches for diabetic cardiomyopathy
por: Lorenzo-Almorós, A., et al.
Publicado: (2017)

Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2013)

Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study
por: Cortés, Marcelino, et al.
Publicado: (2023)

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases
por: Lorenzo-Almorós, A., et al.
Publicado: (2019)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges
por: Méndez-Barbero, Nerea, et al.
Publicado: (2020)

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2011)

Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
por: Fuentes-Antrás, J., et al.
Publicado: (2014)

Tumor Necrosis Factor‐Like Weak Inducer of Apoptosis or Fn14 Deficiency Reduce Elastase Perfusion‐Induced Aortic Abdominal Aneurysm in Mice
por: Tarín, Carlos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_po5tl2nvbi9j2mad343gssm2gj